Affichage de 1–12 sur 29 résultats

AVONEX 30 µg/0,5 ml Luer Lock Inj.Lsg.i.e.Fert.-S.(interferon beta-1a), 4

2,274.47
Outpatient treatment of patients with multiple sclerosis (to reduce the frequency and severity of exacerbations and slow the progression of disability).

AVONEX 30 µg/0,5 ml Luer Lock Inj.Lsg.i.e.Fert.-S.(interferon beta-1a),12

7,255.92
Outpatient treatment of patients with multiple sclerosis (to reduce the frequency and severity of exacerbations and slow the progression of disability).

AVONEX 30 µg/0,5 ml Luer Lock Inj.Lsg.i.e.Fert.-S.(interferon beta-1a),4

2,481.39
Outpatient treatment of patients with multiple sclerosis (to reduce the frequency and severity of exacerbations and slow the progression of disability).

AZZALURE 10 Speyw.E./0,05 ml Plv.z.Her.e.Inj.-Lsg. (Clostridium botulinum), 1 (Kohlpharma GmbH)

185.72
This concentration is used in most international clinical studies of the effectiveness of correction of glabellar wrinkles.

Betaserc (Betahistine) 24mg, 120

0.00
Action pharmacologique - semblable à l'histamine.

Betaserc (Betahistine) 24mg, 50

0.00
Action pharmacologique - semblable à l'histamine.

Betaserc (Betahistine) 24mg, 60

0.00
Action pharmacologique - semblable à l'histamine.

Betaserc (Betahistine) 8mg, 100

0.00
Action pharmacologique - semblable à l'histamine.

Betaserc (Betahistine) 8mg, 30

0.00
Action pharmacologique - semblable à l'histamine.

Betaserc ODT (Betahistine) 24mg, 50

0.00
Action pharmacologique - semblable à l'histamine.

Betaserc ODT (Betahistine) 24mg, 60

0.00
Action pharmacologique - semblable à l'histamine.